These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 35485329)
21. Oseltamivir as a cause of acute enterorrhagia. Beraldi-Magalhães F; Batista V; Cordeiro-Santos M Braz J Infect Dis; 2016; 20(5):521. PubMed ID: 27542865 [No Abstract] [Full Text] [Related]
22. Antiviral drugs in influenza: an adjunct to vaccination in some situations. Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114 [TBL] [Abstract][Full Text] [Related]
23. Oseltamivir for the treatment of H1N1 influenza during pregnancy. Beigi RH; Pillai VC; Venkataramanan R; Caritis SN Clin Pharmacol Ther; 2015 Oct; 98(4):403-5. PubMed ID: 26108913 [TBL] [Abstract][Full Text] [Related]
24. Synergistic effect of nitazoxanide with neuraminidase inhibitors against influenza A viruses in vitro. Belardo G; Cenciarelli O; La Frazia S; Rossignol JF; Santoro MG Antimicrob Agents Chemother; 2015 Feb; 59(2):1061-9. PubMed ID: 25451059 [TBL] [Abstract][Full Text] [Related]
25. Oseltamivir use in infants under one year of age: are there still unanswered questions? Kara A; Karadağ-Oncel E; Ozkaya-Parlakay A; Korukluoğlu G; Bağdat A; Celik M; Ceyhan M; Cengiz AB Turk J Pediatr; 2012; 54(1):25-9. PubMed ID: 22397038 [TBL] [Abstract][Full Text] [Related]
26. Virus load kinetics and resistance development during oseltamivir treatment in infants and children infected with Influenza A(H1N1) 2009 and Influenza B viruses. Rath B; von Kleist M; Tief F; Karsch K; Tuerk E; Muehlhans S; Louis F; Skopnik H; Schweiger B; Duwe S Pediatr Infect Dis J; 2012 Sep; 31(9):899-905. PubMed ID: 22581220 [TBL] [Abstract][Full Text] [Related]
27. The use of antiviral agents for the management of severe influenza. Smith JR; Ariano RE; Toovey S Crit Care Med; 2010 Apr; 38(4 Suppl):e43-51. PubMed ID: 19935416 [TBL] [Abstract][Full Text] [Related]
28. Oseltamivir-induced mania in a patient with H1N1. Ho LN; Chung JP; Choy KL Am J Psychiatry; 2010 Mar; 167(3):350. PubMed ID: 20194491 [No Abstract] [Full Text] [Related]
29. The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo. Ives JA; Carr JA; Mendel DB; Tai CY; Lambkin R; Kelly L; Oxford JS; Hayden FG; Roberts NA Antiviral Res; 2002 Aug; 55(2):307-17. PubMed ID: 12103431 [TBL] [Abstract][Full Text] [Related]
30. Influenza A (H1N1) virus-induced hepatocellular injury in a kidney transplant patient. Daudé M; Mansuy JM; Guitard J; Basse G; Esposito L; Izopet J; Rostaing L; Kamar N Transpl Infect Dis; 2011 Feb; 13(1):70-2. PubMed ID: 20649943 [TBL] [Abstract][Full Text] [Related]
31. Frequency of oseltamivir resistance in Sydney, during the Newcastle outbreak of community transmitted oseltamivir-resistant influenza A(H1N1)pdm09 virus, Australia, June to August 2011. Wang B; Taylor J; Ratnamohan M; McPhie K; Kesson A; Dixit R; Booy R; Hurt A; Saksena N; Dwyer DE Euro Surveill; 2012 Jul; 17(27):. PubMed ID: 22790606 [TBL] [Abstract][Full Text] [Related]
32. Neuraminidase inhibitors for preventing and treating influenza in children. Wang K; Shun-Shin M; Gill P; Perera R; Harnden A Cochrane Database Syst Rev; 2012 Jan; 1():CD002744. PubMed ID: 22258949 [TBL] [Abstract][Full Text] [Related]
33. Systematic review of influenza resistance to the neuraminidase inhibitors. Thorlund K; Awad T; Boivin G; Thabane L BMC Infect Dis; 2011 May; 11():134. PubMed ID: 21592407 [TBL] [Abstract][Full Text] [Related]
34. Oseltamivir-resistant influenza A(H1N1)pdm09 viruses, United States, 2013-14. Okomo-Adhiambo M; Fry AM; Su S; Nguyen HT; Elal AA; Negron E; Hand J; Garten RJ; Barnes J; Xiyan X; Villanueva JM; Gubareva LV; Emerg Infect Dis; 2015 Jan; 21(1):136-41. PubMed ID: 25532050 [TBL] [Abstract][Full Text] [Related]
35. Oseltamivir ring prophylaxis for containment of 2009 H1N1 influenza outbreaks. Lee VJ; Yap J; Cook AR; Chen MI; Tay JK; Tan BH; Loh JP; Chew SW; Koh WH; Lin R; Cui L; Lee CW; Sung WK; Wong CW; Hibberd ML; Kang WL; Seet B; Tambyah PA N Engl J Med; 2010 Jun; 362(23):2166-74. PubMed ID: 20558367 [TBL] [Abstract][Full Text] [Related]
36. Oseltamivir-resistant influenza A 2009 H1N1 virus in immunocompromised patients. Couturier BA; Bender JM; Schwarz MA; Pavia AT; Hanson KE; She RC Influenza Other Respir Viruses; 2010 Jul; 4(4):199-204. PubMed ID: 20836794 [TBL] [Abstract][Full Text] [Related]
37. Pandemic H1N1 2009 influenza virus with the H275Y oseltamivir resistance neuraminidase mutation shows a small compromise in enzyme activity and viral fitness. Brookes DW; Miah S; Lackenby A; Hartgroves L; Barclay WS J Antimicrob Chemother; 2011 Mar; 66(3):466-70. PubMed ID: 21172786 [TBL] [Abstract][Full Text] [Related]
38. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Jefferson T; Jones MA; Doshi P; Del Mar CB; Heneghan CJ; Hama R; Thompson MJ Cochrane Database Syst Rev; 2012 Jan; 1():CD008965. PubMed ID: 22258996 [TBL] [Abstract][Full Text] [Related]
39. Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010. Meijer A; Jonges M; Abbink F; Ang W; van Beek J; Beersma M; Bloembergen P; Boucher C; Claas E; Donker G; van Gageldonk-Lafeber R; Isken L; de Jong A; Kroes A; Leenders S; van der Lubben M; Mascini E; Niesters B; Oosterheert JJ; Osterhaus A; Riesmeijer R; Riezebos-Brilman A; Schutten M; Sebens F; Stelma F; Swaan C; Timen A; van 't Veen A; van der Vries E; te Wierik M; Koopmans M Antiviral Res; 2011 Oct; 92(1):81-9. PubMed ID: 21767571 [TBL] [Abstract][Full Text] [Related]
40. Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season. Okomo-Adhiambo M; Sleeman K; Lysén C; Nguyen HT; Xu X; Li Y; Klimov AI; Gubareva LV Influenza Other Respir Viruses; 2013 Sep; 7(5):645-58. PubMed ID: 23575174 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]